39 related articles for article (PubMed ID: 18825535)
1. Bacterial expression, purification, and reconstitution of human steroid 5α-reductases in phospholipid liposomes and nanodiscs.
Im SC; Valentín-Goyco J; Peng HM; Auchus RJ
Methods Enzymol; 2023; 689():263-276. PubMed ID: 37802573
[TBL] [Abstract][Full Text] [Related]
2. In vitro effect of D-004, a lipid extract of the fruit of the cuban royal palm (Roystonea regia), on prostate steroid 5α-reductase activity.
Pérez LY; Menéndez R; Má R; González RM
Curr Ther Res Clin Exp; 2006 Nov; 67(6):396-405. PubMed ID: 24678112
[TBL] [Abstract][Full Text] [Related]
3. Structure of human steroid 5α-reductase 2 with anti-androgen drug finasteride.
Xiao Q; Wang L; Supekar S; Shen T; Liu H; Ye F; Huang J; Fan H; Wei Z; Zhang C
Res Sq; 2020 Jul; ():. PubMed ID: 32702725
[TBL] [Abstract][Full Text] [Related]
4. Association of 5α-Reductase Inhibitor Use With Prostate Cancer-Specific Mortality.
Stroomberg HV; Brasso K; Røder A
JAMA Oncol; 2022 Oct; ():. PubMed ID: 36227624
[No Abstract] [Full Text] [Related]
5. Association of 5α-Reductase Inhibitor Use With Prostate Cancer-Specific Mortality-Reply.
Björnebo L; Eklund M; Lantz A
JAMA Oncol; 2022 Oct; ():. PubMed ID: 36227621
[No Abstract] [Full Text] [Related]
6. Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases.
Cabeza M; Sánchez-Márquez A; Garrido M; Silva A; Bratoeff E
Curr Med Chem; 2016; 23(8):792-815. PubMed ID: 26861003
[TBL] [Abstract][Full Text] [Related]
7. Activity landscape analysis of novel 5α-reductase inhibitors.
Naveja JJ; Cortés-Benítez F; Bratoeff E; Medina-Franco JL
Mol Divers; 2016 Aug; 20(3):771-80. PubMed ID: 26829939
[TBL] [Abstract][Full Text] [Related]
8. 5alpha-reductase inhibitors.
Rittmaster RS
J Androl; 1997; 18(6):582-7. PubMed ID: 9432130
[No Abstract] [Full Text] [Related]
9. Actions of 5alpha-reductase inhibitors on the epididymis.
Robaire B; Henderson NA
Mol Cell Endocrinol; 2006 May; 250(1-2):190-5. PubMed ID: 16476520
[TBL] [Abstract][Full Text] [Related]
10. Aromatic esters of progesterone as 5alpha-reductase and prostate growth inhibitors.
Bratoeff E; Segura T; Recillas S; Carrizales E; Palacios A; Heuze I; Cabeza M
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):655-62. PubMed ID: 18825535
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of progesterone derivatives as 5alpha-reductase inhibitors, and their effect on hamster prostate weight.
Bratoeff E; Zambrano A; Heuze I; Palacios A; Ramírez D; Cabeza M
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):306-11. PubMed ID: 19874206
[TBL] [Abstract][Full Text] [Related]
12. Novel C-6 substituted and unsubstituted pregnane derivatives as 5alpha-reductase inhibitors and their effect on hamster flank organs diameter size.
Cabeza M; Zambrano A; Heuze I; Carrizales E; Palacios A; Segura T; Valencia N; Bratoeff E
Steroids; 2009 Oct; 74(10-11):793-802. PubMed ID: 19406144
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453
[TBL] [Abstract][Full Text] [Related]
14. Molecular interactions of progesterone derivatives with 5 alpha-reductase types 1 and 2 and androgen receptors.
Bratoeff E; García P; Heuze Y; Soriano J; Mejía A; Labastida AM; Valencia N; Cabeza M
Steroids; 2010 Jul; 75(7):499-505. PubMed ID: 20359488
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
